Skip to main content
SpringerLink
Log in

Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Patients with non-valvular atrial fibrillation (AF) have an elevated stroke risk that is 2–7 times greater than in those without AF. Intravenous unfractionated heparin (UFH) is commonly used for hospitalized patients with atrial fibrillation and atrial flutter (AFL) to prevent stroke. Dosing strategies exist for intravenous anticoagulation in patients with acute coronary syndromes and venous thromboembolic diseases, but there are no data to guide providers on a dosing strategy for intravenous anticoagulation in patients with AF/AFL. 996 hospitalized patients with AF/AFL on UFH were evaluated. Bolus dosing and initial infusion rates of UFH were recorded along with rates of stroke, thromboemobolic events, and bleeding events as defined by the International Society on Thrombosis and Haemostasis criteria. Among 226 patients included in the analysis, 76 bleeding events occurred. Using linear regression analysis, initial rates of heparin infusion ranging from 9.7 to 11.8 units/kilogram/hour (U/kg/h) resulted in activated partial thromboplastin times that were within therapeutic range. The median initial infusion rate in patients with bleeding was 13.3 U/kg/h, while in those without bleeding it was 11.4 U/kg/h; p = 0.012. An initial infusion rate >11.0 U/kg/h yielded an OR 1.95 (1.06–3.59); p = 0.03 for any bleeding event. Using IV heparin boluses neither increased the probability of attaining a therapeutic aPTT (56.1 vs 56.3 %; p = 0.99) nor did it significantly increase bleeding events in the study (35.7 vs 31.3 %; p = 0.48). The results suggest that higher initial rates of heparin are associated with increased bleeding risk. From this dataset, initial heparin infusion rates of 9.7–11.0 U/kg/h without a bolus can result in therapeutic levels of anticoagulation in hospitalized patients with AF/AFL without increasing the risk of bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48(4):854–906. doi:10.1016/j.jacc.2006.07.009

    Article  PubMed  Google Scholar 

  2. Naccarelli GV, Varker H, Lin J, Schulman KL (2009) Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 104(11):1534–1539. doi:10.1016/j.amjcard.2009.07.022

    Article  PubMed  Google Scholar 

  3. Smoyer-Tomic K, Siu K, Walker DR, Johnson BH, Smith DM, Sander S, Amin A (2012) Anticoagulant use, the prevalence of bridging, and relation to length of stay among hospitalized patients with non-valvular atrial fibrillation. Am J Cardiovasc Drugs 12(6):403–413. doi:10.2165/11633750-000000000-00000

    PubMed  PubMed Central  Google Scholar 

  4. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R (2012) Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e326S–e350S. doi:10.1378/chest.11-2298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GY (2012) Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e531S–e575S. doi:10.1378/chest.11-2304

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Goldhaber SZ (2006) “Bridging” and mechanical heart valves: perils, promises, and predictions. Circulation 113(4):470–472. doi:10.1161/CIRCULATIONAHA.105.598268

    Article  PubMed  Google Scholar 

  7. Hochman JS, Wali AU, Gavrila D, Sim MJ, Malhotra S, Palazzo AM, De La Fuente B (1999) A new regimen for heparin use in acute coronary syndromes. Am Heart J 138(2 Pt 1):313–318

    CAS  PubMed  Google Scholar 

  8. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S (1993) The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Ann Intern Med 119(9):874–881

    Article  CAS  PubMed  Google Scholar 

  9. Zimmermann AT, Jeffries WS, McElroy H, Horowitz JD (2003) Utility of a weight-based heparin nomogram for patients with acute coronary syndromes. Int Med J 33(1–2):18–25

    Article  CAS  Google Scholar 

  10. White RH, Zhou H, Woo L, Mungall D (1997) Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements. Arch Intern Med 157(21):2468–2472

    Article  CAS  PubMed  Google Scholar 

  11. Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W (2010) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 8(1):202–204. doi:10.1111/j.1538-7836.2009.03678.x

    Article  CAS  PubMed  Google Scholar 

  12. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. doi:10.1016/j.jbi.2008.08.010

    Article  PubMed  Google Scholar 

  13. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272. doi:10.1378/chest.09-1584

    Article  PubMed  Google Scholar 

  14. Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE (2003) Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290(20):2685–2692. doi:10.1001/jama.290.20.2685

    Article  CAS  PubMed  Google Scholar 

  15. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D’Agostino RB (1996) Stroke severity in atrial fibrillation. The Framingham Study. Stroke 27(10):1760–1764

    Article  CAS  PubMed  Google Scholar 

  16. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988

    Article  CAS  PubMed  Google Scholar 

  17. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS (1996) Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 27(10):1765–1769

    Article  CAS  PubMed  Google Scholar 

  18. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P (2006) Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 9(5):348–356. doi:10.1111/j.1524-4733.2006.00124.x

    Article  PubMed  Google Scholar 

  19. Mercaldi CJ, Siu K, Sander SD, Walker DR, Wu Y, Li Q, Wu N (2012) Long-term costs of ischemic stroke and major bleeding events among medicare patients with nonvalvular atrial fibrillation. Cardiol Res Pract 2012:645469. doi:10.1155/2012/645469

    PubMed  PubMed Central  Google Scholar 

  20. Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL, Investigators B (2015) Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 373(9):823–833. doi:10.1056/NEJMoa1501035

    Article  CAS  PubMed  Google Scholar 

  21. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370–2375

    Article  CAS  PubMed  Google Scholar 

  22. Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL (2011) Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 4(3):313–320. doi:10.1161/CIRCOUTCOMES.110.958165

    Article  PubMed  Google Scholar 

  23. Chiu HM, van Aken WG, Hirsh J, Regoeczi E, Horner AA (1977) Increased heparin clearance in experimental pulmonary embolism. J Lab Clin Med 90(1):204–215

    CAS  PubMed  Google Scholar 

  24. Hirsh J (1991) Heparin. N Engl J Med 324(22):1565–1574. doi:10.1056/NEJM199105303242206

    Article  CAS  PubMed  Google Scholar 

  25. Hirsh J, van Aken WG, Gallus AS, Dollery CT, Cade JF, Yung WL (1976) Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation 53(4):691–695

    Article  CAS  PubMed  Google Scholar 

  26. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116(7):e148–e304. doi:10.1161/CIRCULATIONAHA.107.181940

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Leon H. Charney Division of Cardiology, The Department of Medicine, New York University School of Medicine, 550 First Ave, NBV 10W17, New York, NY, 10016, USA

    Robert O. Roswell, Brian Greet, Sunny Shah, Samuel Bernard, Alexandra Milin, Iryna Lobach, Yu Guo, Martha J. Radford & Jeffrey S. Berger

Authors
  1. Robert O. Roswell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian Greet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sunny Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Samuel Bernard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexandra Milin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Iryna Lobach
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yu Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Martha J. Radford
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jeffrey S. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert O. Roswell.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roswell, R.O., Greet, B., Shah, S. et al. Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias. J Thromb Thrombolysis 42, 179–185 (2016). https://doi.org/10.1007/s11239-016-1347-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-016-1347-2

Keywords

Search

Navigation